Theo-24 and Xolair drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Theo-24 (theophylline) and Xolair (omalizumab). Common drug interactions include arthralgia among females and malaise among males.
The phase IV clinical study analyzes what interactions people have when they take Theo-24 and Xolair. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.
What is Theo-24?
Theo-24 has active ingredients of theophylline. It is often used in asthma. eHealthMe is studying from 436 Theo-24 users. Check the latest studies of Theo-24.
What is Xolair?
Xolair has active ingredients of omalizumab. It is often used in asthma. eHealthMe is studying from 77,554 Xolair users. Check the latest studies of Xolair.
32 people who take Theo-24 and Xolair together, and have interactions are studied.

What are the common drug interactions of Theo-24 and Xolair, by gender? *:
female:
- Arthralgia (joint pain)
- Sinusitis (inflammation of sinus)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Skin lesion
- Adverse drug reaction
- Adverse event
- Alopecia (absence of hair from areas of the body)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Blood urine present
- Cardiac failure congestive
male:
- Malaise (a feeling of general discomfort or uneasiness)
- Arthralgia (joint pain)
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Growth retardation (delayed growth)
- Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
- Localised infection (infection at the single location)
- Lymphadenopathy (disease or enlargement of lymph nodes)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Mycoplasma infection (bacterial infection)
What are the common drug interactions of Theo-24 and Xolair, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Adverse drug reaction
- Adverse event
- Arthralgia (joint pain)
- Fall
- Grip strength decreased
- Headache (pain in head)
- Hypokinesia (decreased bodily movement)
- Influenza like illness
- Infusion site extravasation (flow of (blood or lymph) from infusion site)
- Insomnia (sleeplessness)
50-59:
- Arthralgia (joint pain)
- Pruritus (severe itching of the skin)
60+:
- Arthralgia (joint pain)
- Cough
- Polymyalgia rheumatica (pain in many muscles)
- Temporal arteritis (inflammation and damage to blood vessels that supply the head area)
- Wrist fracture
- Upper respiratory tract infection
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cardiac failure congestive
What are the existing conditions these people have? *
- Immunodeficiency Common Variable: 5 people, 15.62%
- Pain: 2 people, 6.25%
- Hypersensitivity: 2 people, 6.25%
- Acute Severe Asthma: 2 people, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Theo-24 and Xolair?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Theo-24 and Xolair:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Theo-24:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Xolair:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Theo-24 and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Xolair and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
- Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
- Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
- Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on theophylline and omalizumab (the active ingredients of Theo-24 and Xolair, respectively), and Theo-24 and Xolair (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zoloft cause Sleep Paralysis? - 2 seconds ago
- Vesicare vs. Tolterodine, side effect and effectiveness comparison - 12 seconds ago
- Drug interactions of Glucovance and Flomax - 31 seconds ago
- Could Exjade cause Constipation? - 34 seconds ago
- Drug interactions of Idarubicin Hydrochloride and Ambisome - 46 seconds ago
- Drug interactions of Codeine and Avodart - 47 seconds ago
- Drug interactions of Melphalan and Diovan - a minute ago
- Could Naproxen cause Hypertrophic Cardiomyopathy? - a minute ago
- Drug interactions of Melphalan Hydrochloride and Paxil - a minute ago
- Could Tamoxifen Citrate cause Speech Impairment (Adult)? - a minute ago